Carl Zeiss Shares Outstanding vs. Revenue
| CZMWY Stock | USD 60.09 0.28 0.47% |
For Carl Zeiss profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Carl Zeiss to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Carl Zeiss Meditec utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Carl Zeiss's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Carl Zeiss Meditec over time as well as its relative position and ranking within its peers.
Carl |
Carl Zeiss Meditec Revenue vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Carl Zeiss's current stock value. Our valuation model uses many indicators to compare Carl Zeiss value to that of its competitors to determine the firm's financial worth. Carl Zeiss Meditec is rated below average in shares outstanding category among its peers. It also is rated below average in revenue category among its peers totaling about 21.27 of Revenue per Shares Outstanding. Comparative valuation analysis is a catch-all model that can be used if you cannot value Carl Zeiss by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Carl Zeiss' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Carl Revenue vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Carl Zeiss |
| = | 89.44 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Carl Zeiss |
| = | 1.9 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Carl Revenue vs Competition
Carl Zeiss Meditec is rated below average in revenue category among its peers. Market size based on revenue of Medical Instruments & Supplies industry is currently estimated at about 1.12 Trillion. Carl Zeiss adds roughly 1.9 Billion in revenue claiming only tiny portion of all equities under Medical Instruments & Supplies industry.
Carl Zeiss Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Carl Zeiss, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Carl Zeiss will eventually generate negative long term returns. The profitability progress is the general direction of Carl Zeiss' change in net profit over the period of time. It can combine multiple indicators of Carl Zeiss, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3531 people.
Carl Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Carl Zeiss. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Carl Zeiss position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Carl Zeiss' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Carl Zeiss without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Use Investing Themes to Complement your Carl Zeiss position
In addition to having Carl Zeiss in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Currency ETFs Thematic Idea Now
Alternative Currency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Alternative Currency ETFs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Currency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Carl Pink Sheet Analysis
When running Carl Zeiss' price analysis, check to measure Carl Zeiss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carl Zeiss is operating at the current time. Most of Carl Zeiss' value examination focuses on studying past and present price action to predict the probability of Carl Zeiss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carl Zeiss' price. Additionally, you may evaluate how the addition of Carl Zeiss to your portfolios can decrease your overall portfolio volatility.